Blue Matter Enhances Twine™ Platform Capabilities in Response to Growing Demand
Blue Matter today announced the expansion of its Twine™ data platform’s capabilities in response to accelerating demand from biopharma companies. Enhancements include thoughtful use of artificial intelligence (AI) for advanced analytics and narratives, expanded data source integrations, master data management, and broader deployment across oncology and specialty therapeutic areas.
Blue Matter Hires New Partner, Eva Kersey, Further Strengthening Capabilities in Europe
Blue Matter is pleased to announce that Eva Kersey has joined the firm as a Partner based in London. Eva officially joined the Blue Matter team on September 16, bringing a broad base of strategic consulting experience across pharmaceutical, biotech, and medical technology clients.
Blue Matter Hires New Partner, Jenna Riffell, Strengthening Capabilities in Europe
Blue Matter is pleased to announce that Jenna Riffell has joined as a Partner based in London. Jenna officially joined the firm on April 15 and brings a broad base of consulting experience that will strengthen the firm’s capabilities across Europe.
